CDC Releases Interim Guidance on COVID-19 Serology Testing

CDC has developed interim guidance for antibody testing for SARS-CoV-2, the virus that causes COVID-19. The guidance is for healthcare providers, clinical laboratory professionals, and public health officials and includes information about types of antibody testing, limitations of serologic tests, strategies for optimizing testing outcomes, and recommendations for using serologic tests and interpreting their results.

SARS-CoV-2 is an emerging virus, and what is known about it is rapidly evolving. CDC will update this guidance as additional information becomes available.

Online resources:

• Clinical Laboratory COVID-19 Response Weekly Calls
• CDC's Laboratory Outreach Communication System (LOCS)
• COVID-19 Information for Laboratories
• CDC COVID-19 website
• Register for CDC Health Alert Network (HAN) notifications, including updates about COVID-19. Enter your email address, search for HAN and sign up.

To read more articles from this issue of ePolicy, click here. To learn more about ePolicy News and access past newsletters and articles, click here.

For more information regarding ASCP's advocacy initiatives and policy positions, please contact ASCP's Center for Public Policy at (202) 408-1110.

ASCP ePolicy News is supported by an unrestricted grant from Hologic.